1.
Folia Med (Plovdiv)
; 65(4): 605-611, 2023 Aug 31.
Artículo
en Inglés
| MEDLINE
| ID: mdl-37655379
RESUMEN
INTRODUCTION: Anti-tumor necrosis factor (anti-TNF) therapy has become a mainstay in the treatment of patients with inflammatory bowel disease over the past few decades.